1/26/2009

BVF Acquisition, the largest shareholder in Avigen, is offering to buy the biotech firm for $20.9 million so it can merge with MediciNova. BVF's offer, which expires Feb. 23, comes a month after MediciNova proposed to acquire Avigen.

Related Summaries